{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:40:25Z","timestamp":1786653625524,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>This study aimed to identify the prognostic factors that influence the recurrence, progression, and multiple recurrences of non-muscle-invasive bladder cancerr (NMIBC) based on data from the Hualien Tzu Chi Hospital, Taiwan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A retrospective cohort study enrolled patients with NMIBC diagnosed between 2005 and 2022 who underwent transurethral resection of bladder tumor (TUR-BT). Demographic, clinical, and pathological data, along with recurrence outcomes, were collected. Cox proportional hazard regression models were used to analyze the factors associated with recurrence, progression to muscle-invasive disease, and risk for multiple recurrences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Overall, 199 patients were included, with a mean follow-up duration of 4.6 years. Tumors recurred in 53.8% of the patients, which further progressed to muscle-invasive bladder cancer (MIBC) in 13.1%. Multivariate Cox regression analysis identified betel nut chewing, multiple tumors, high-grade tumors, and lack of bacillus Calmette\u2013Gu\u00e9rin (BCG) therapy as significant predictors of recurrence. Age, high-grade tumors, and recurrence within 3 months after the initial TUR-BT were the significant predictors of progression. Multiple tumors and early recurrence occurring within 3 months after the initial TUR-BT were significantly associated with the risk of experiencing multiple recurrences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study identified multiple tumors, high-grade tumors, and BCG therapy as the significant factors associated with NMIBC recurrence, with a potential link also observed for betel nut chewing. Age, tumor grade, and early recurrence emerged as the key predictors of progression to MIBC. In addition, multiple tumors and early recurrence were linked to an increased risk of experiencing multiple recurrences.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tcmj.tcmj_78_25","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T12:34:16Z","timestamp":1760358856000},"page":"83-89","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic factors for the recurrence, progression, and multiple recurrences of non-muscle-invasive bladder cancer in Eastern Taiwan"],"prefix":"10.4103","volume":"38","author":[{"given":"Ti-Chia","family":"Kung","sequence":"first","affiliation":[{"name":"Department of Medical Education, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"R1-20260116","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20260116","year":"2021","journal-title":"Health Promotion Administration, Ministry of Health and Welfare. Cancer Registry Annual Report, Taiwan"},{"key":"R3-20260116","article-title":"EAU Guidelines","author":"Gontero","year":"2024","journal-title":"Presented at the EAU Annual Congress Paris"},{"key":"R4-20260116","doi-asserted-by":"crossref","first-page":"20.e1","DOI":"10.1016\/j.urolonc.2014.09.001","article-title":"Long-term follow-up of TaG1 non-muscle-invasive bladder cancer","volume":"33","author":"Olivier Bosset","year":"2015","journal-title":"Urol Oncol"},{"key":"R5-20260116","doi-asserted-by":"crossref","first-page":"704902","DOI":"10.3389\/fsurg.2021.704902","article-title":"T1 bladder cancer: Comparison of the prognostic impact of two substaging systems on disease recurrence and progression and suggestion of a novel nomogram","volume":"8","author":"Asimakopoulos","year":"2021","journal-title":"Front Surg"},{"key":"R6-20260116","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"R7-20260116","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus calmette-guerin: The CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"R8-20260116","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) Prognostic factor risk groups for Non-muscle-invasive Bladder Cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: An update from the EAU NMIBC guidelines panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"},{"key":"R9-20260116","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"R10-20260116","doi-asserted-by":"crossref","first-page":"216","DOI":"10.6004\/jnccn.2024.0024","article-title":"NCCN guidelines\u00aeinsights: Bladder cancer, version 3.2024","volume":"22","author":"Flaig","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"R11-20260116","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001986","article-title":"Intravesical bacillus calmette-guerin in Ta and T1 bladder cancer","author":"Shelley","year":"2000","journal-title":"Cochrane Database Syst Rev 2000"},{"key":"R12-20260116","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.ju.0000162059.64886.1c","article-title":"Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: A meta-analysis of the published results of randomized clinical trials","volume":"174","author":"Sylvester","year":"2005","journal-title":"J Urol"},{"key":"R13-20260116","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-0714.1995.tb01132.x","article-title":"Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan","volume":"24","author":"Ko","year":"1995","journal-title":"J Oral Pathol Med"},{"key":"R14-20260116","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ijc.21237","article-title":"Different impact from betel quid, alcohol and cigarette: Risk factors for pharyngeal and laryngeal cancer","volume":"117","author":"Lee","year":"2005","journal-title":"Int J Cancer"},{"key":"R15-20260116","doi-asserted-by":"crossref","first-page":"102526","DOI":"10.1016\/j.canep.2024.102526","article-title":"Association of alcohol consumption, betel nut chewing, and cigarette smoking with mortality in patients with head and neck cancer among the Taiwanese population: A nationwide population-based cohort study","volume":"89","author":"Su","year":"2024","journal-title":"Cancer Epidemiol"},{"key":"R16-20260116","first-page":"1427","article-title":"Cancer risks from betel quid chewing beyond oral cancer: A multiple-site carcinogen when acting with smoking","volume":"21","author":"Wen","year":"2010","journal-title":"Cancer Causes Control"},{"key":"R17-20260116","doi-asserted-by":"crossref","first-page":"29466","DOI":"10.1038\/srep29466","article-title":"Areca nut chewing and an impaired estimated glomerular filtration rate as significant risk factors for non-muscle-invasive bladder cancer recurrence","volume":"6","author":"Cao","year":"2016","journal-title":"Sci Rep"},{"key":"R18-20260116","first-page":"407","article-title":"Trends in betel quid chewing behavior in Taiwan-exploring the relationship between betel quid chewing and smoking","volume":"28","author":"Wen","year":"2009","journal-title":"Taiwan J Public Health"},{"key":"R19-20260116","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1007\/s00432-022-04464-6","article-title":"The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: A systematic review and meta-analysis","volume":"149","author":"\u015alusarczyk","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"R20-20260116","doi-asserted-by":"crossref","first-page":"431.e7","DOI":"10.1016\/j.urolonc.2023.05.019","article-title":"Underutilization of intravesical chemotherapy and immunotherapy for high grade non-muscle invasive bladder cancer in California between 2006-2018: Effect of race, age and socioeconomic status on treatment disparities","volume":"41","author":"Noel","year":"2023","journal-title":"Urol Oncol"},{"key":"R21-20260116","year":"2021","journal-title":"Health Promotion Administration, Ministry of Health and Welfare. National health Survey on betel Nut Chewing Among Taiwanese aged 18 and Above \u2013 Statistics by Gender, age, and Residence Area (county\/city, Taiwan)"},{"key":"R22-20260116","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.eururo.2007.10.006","article-title":"Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin: Multivariate analysis of data from four randomized CUETO trials","volume":"53","author":"Fernandez-Gomez","year":"2008","journal-title":"Eur Urol"},{"key":"R23-20260116","first-page":"3681","article-title":"Shorter recurrence-free survival time, higher risk of multiple recurrences: A retrospective study of non-muscle invasive bladder cancer after transurethral resection","volume":"125","author":"Deng","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"R24-20260116","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijsu.2018.02.045","article-title":"Maintenance versus non-maintenance intravesical Bacillus Calmette-Guerin instillation for non-muscle invasive bladder cancer: A systematic review and meta-analysis of randomized clinical trials","volume":"52","author":"Chen","year":"2018","journal-title":"Int J Surg"}],"container-title":["Tzu Chi Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_78_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:40:08Z","timestamp":1786650008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_78_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/tcmj.tcmj_78_25","relation":{},"ISSN":["1016-3190","2223-8956"],"issn-type":[{"value":"1016-3190","type":"print"},{"value":"2223-8956","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"2025-02-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}